CVRx, Inc.
CVRX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001235912
In the last 90 days, CVRx, Inc. insiders filed 1 open-market purchase and 1 sale; 87 institutions reported holding it in 13F filings for Q2 2026, worth $78.7M in total; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $76.4K in total
- 1
- Insider sellsLast 90 days, $3.34K in total
- 1
- 13F holdersQ2 2026, −10 vs. previous quarter
- 87
- 13F valueReported value at the end of Q2 2026
- $78.7M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding CVRX, Q2 2026
No superinvestor reported holding CVRX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by CVRx, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 (view filing)8:18 PM ET | Aug 13 | Same day | Binkowski BrentCHIEF OPERATING OFFICER | PPurchase | +26.2K | $2.91 | +$76.4K | +86.6%56.5K after | |
| Aug 13, 2026 (view filing)4:26 PM ET | Aug 12 | 1 day | Binkowski BrentCHIEF OPERATING OFFICER | SSale | −1.31K | $2.55 | −$3.34K | −4.1%30.3K after | 10b5-1 |
| Mar 16, 2026 (view filing) | Mar 2 | 14 daysLate | Adamson Philip B.Chief Medical Officer | SSale | −1.26K | $7.90 | −$9.97K | −2.0%61.6K after | 10b5-1 |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | John Robert AllenChief Revenue Officer | SSale | −3.96K | $7.90 | −$31.3K | −4.4%86.0K after | 10b5-1 |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Verrastro PaulCHIEF MKTG & STRAT OFFICER | SSale | −1.28K | $7.90 | −$10.1K | −2.1%60.6K after | 10b5-1 |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Oasheim JaredCHIEF FINANCIAL OFFICER | SSale | −1.74K | $7.90 | −$13.8K | −1.8%96.7K after | 10b5-1 |
| Mar 3, 2026 (view filing) | Mar 2 | 1 day | Hykes KevinPRES & CEO | SSale | −7.76K | $7.90 | −$61.3K | −2.7%284.2K after | 10b5-1 |
| Feb 23, 2026 (view filing) | Feb 20 | 3 days | Jain Mudit K.Director | PPurchase | +46.8K | $6.36 | +$297.6K | +5.0%980.2K after | |
| Feb 18, 2026 (view filing) | Feb 18 | Same day | Jain Mudit K.Director | PPurchase | +600 | $4.64 | +$2.78K | +11.9%5.65K after | |
| Jan 8, 2026 (view filing)4:05 PM ET | Nov 25-26, 2025 | 44 days | Johnson & Johnson and 1 other10% Owner | SSale | −22.3K | $10.03 | −$224.0K | −0.6%4.02M after | Amended2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in CVRx, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Johnson & Johnson | 4,024,861 | $20.7M | 2.59% | 00.0% | Unchanged |
| NEA Management Company, LLC | 1,954,440 | $10.0M | 0.63% | −71,643−3.5% | Reduced |
| BlackRock, Inc. | 1,245,459 | $6.40M | 0.00% | +218,900+21.3% | Added |
| Royal Bank of Canada | 1,233,212 | $6.34M | 0.00% | +526,262+74.4% | Added |
| GSK plc | 1,007,583 | $5.18M | 0.86% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 910,576 | $4.68M | 0.00% | −734−0.1% | Reduced |
| Silvercrest Asset Management Group LLC | 878,109 | $4.51M | 0.03% | +306,088+53.5% | Added |
| Geode Capital Management, LLC | 440,786 | $2.27M | 0.00% | +13,714+3.2% | Added |
| PFM Health Sciences, LP | 369,572 | $1.90M | 0.16% | +369,572 | New |
| State Street Corp | 366,352 | $1.88M | 0.00% | +15,804+4.5% | Added |